Prestige Brands


Prestige Brands Holdings Inc. rallied the most since its 2005 initial public offering. Genomma Lab Internacional made an unsolicited offer to buy all outstanding common shares of Prestige - an Irvington, N.Y.-based company that makes products such as Comet, Clear Eyes eye care products, and PediaCare - for $16.60 per share, valuing the company at $834 million. Prestige said it will review the offer.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of